Department of Electrical Engineering in National Cheng Kung University, Tainan, Taiwan; Department of Mechanical Engineering, National Chung Cheng University, Chia-Yi, Taiwan.
Talanta. 2013 Nov 15;116:704-11. doi: 10.1016/j.talanta.2013.07.064. Epub 2013 Jul 31.
Point-of-care diagnostics (POCD) for blood coagulation benefit patients on-site, but available POCD devices are too expensive to be affordable in many countries. Optically based methodologies are cheap and reliable, and have been exploited in bench-top coagulometers to monitor coagulation with plasma, but not whole blood, which contains cellular components that cause massive interference. However, the POCD testing of whole blood gives a more accurate picture of physiological conditions than does testing plasma. In this study, a portable device for performing the prothrombin time (PT) test was designed, comprising an optical sensor, an electrical processing and control circuit to monitor the optical changes that occurred during the coagulation process in whole blood. The PT was when the slope of the first-order derivative of the coagulation curve, recorded from real-time light transmittance signals, was maximal. The POCD PT testing of 167 samples revealed that 153 (91.6%) were successfully detected and the results were highly consistent with the results of whole blood international normalized ratio (INR) (r=0.985, p<0.001) by the conventional manual method and those of plasma INR (r=0.948, p<0.001) with the ACL TOP 700 bench-top coagulometer (Beckman Colter). Hematological parameters were further analyzed, revealing that fibrinogen titers (p=0.036), red blood cell numbers (p=0.017) and distribution of red cell width (p=0.015) affected the effectiveness of the current POCD PT determination. Furthermore, a highly positive correlation was revealed between fibrinogen titers and the maximum speed of change in transmittance (v/t) (r=0.805, p<0.001), suggesting that fibrinogen might be evaluated simultaneously in this POCD testing. In conclusion, the proposed portable optical-based device performs the highly sensitive and accurate determination of whole blood PT and has commercial potential because of its small volume and low fabrication cost.
即时凝血诊断(POCD)有益于现场的患者,但可用的 POCD 设备过于昂贵,在许多国家都难以负担。基于光学的方法既便宜又可靠,已被用于台式凝血仪来监测血浆的凝血情况,但不能监测全血,因为全血中含有细胞成分,会造成严重干扰。然而,POCD 对全血的检测比对血浆的检测能更准确地反映生理状况。在这项研究中,设计了一种用于进行凝血酶原时间(PT)测试的便携式设备,该设备包括一个光学传感器、一个电子处理和控制电路,用于监测全血在凝血过程中发生的光学变化。PT 是指从实时透光率信号记录的凝血曲线一阶导数的斜率达到最大值时的时间。对 167 个样本的 POCD PT 检测结果表明,成功检测到了 153 个(91.6%),且与传统手工方法的全血国际标准化比值(INR)(r=0.985,p<0.001)和 ACL TOP 700 台式凝血仪(贝克曼库尔特)的血浆 INR(r=0.948,p<0.001)的结果高度一致。进一步分析血液学参数,发现纤维蛋白原浓度(p=0.036)、红细胞数量(p=0.017)和红细胞宽度分布(p=0.015)影响当前 POCD PT 测定的效果。此外,还发现纤维蛋白原浓度与透光率变化的最大速度(v/t)之间存在高度正相关(r=0.805,p<0.001),表明在这种 POCD 检测中可以同时评估纤维蛋白原。总之,所提出的便携式光学基设备可实现对全血 PT 的高灵敏度和精确测定,由于其体积小、制造成本低,具有商业潜力。